AUS
NZ
UK
CA
USA
IND
Health
Institutional Investors Adjust Positions in Johnson & Johnson
November 11, 2024 09:46 PM PST| By Team Kalkine MediaHeadlines,Troy Asset Management's Position in Johnson & Johnson,Recent Changes in Institutional Holdings of JNJ,Institutional Ownership of Johnson & Johnson,Troy Asset Management Ltd has adjusted its position in Johnson & Johnson,(NYSE:JNJ),, reducin...
Institutional Investors Show Growing Interest in Kenvue Inc.
November 11, 2024 09:38 PM PST| By Team Kalkine MediaHeadlines,Institutional investors increase their stakes in Kenvue Inc.,XML Financial LLC acquires significant position in Kenvue,Strong institutional ownership signals confidence in Kenvue’s future,XML Financial LLC has recently expanded its presence...
Humana Announces Reliable Dividend Payout with Strong Growth History
November 11, 2024 06:47 PM PST| By Team Kalkine MediaHeadlines,Humana’s Dividend Payment Shows Reliability,Company’s Earnings and Cash Flow Can Support Dividend Payout,Strong History of Growing Dividend Payments Over Time,Humana Inc.,(NYSE:HUM),has announced a dividend payment of $0.885 per share, set...
Why Is Diamond Hill Doubling Down on Pfizer? Is There Cause for Concern?
November 11, 2024 04:32 AM PST| By Team Kalkine MediaHighlights,Diamond Hill Capital Management Inc. raised its Pfizer holdings in the recent quarter.,The firm now owns over sixteen million shares of Pfizer, representing nearly two percent of its portfolio.,Pfizer remains one of Diamond Hill’s top twen...
Why Are Institutional Investors Eyeing Hemogenyx’s CAR-T Therapy So Closely?
November 11, 2024 02:28 AM PST| By Team Kalkine MediaHighlights,Hemogenyx Pharmaceuticals secures funding for phase I trials of its HEMO-CAR-T therapy.,The therapy focuses on targeting acute myeloid leukemia, a severe blood cancer.,Funding supports advancement in developing innovative blood disease tre...
RadNet (NASDAQ:RDNT) Reports Q3 2024 Results with Higher Revenue and Growth Across Key Metrics
November 10, 2024 08:08 PM PST| By Team Kalkine MediaHighlights,Revenue Hits Record $461.1M, Up 14.7% YoY,AI Revenue Soars 75.8%, Boosting Digital Health Segment,Strong Financial Position with $748.9M in Cash, Net Debt to EBITDA Below 1x,RadNet (NASDAQ:RDNT), a leader in the U.S. outpatient imaging ser...
Assetmark Inc. Increases Stake in AbbVie, Strengthening Institutional Support
November 10, 2024 07:43 AM PST| By Team Kalkine MediaHeadlines,Assetmark Inc. raises stake in AbbVie Inc. (NYSE),Institutional investors boost their positions in AbbVie,Strong institutional support for AbbVie as asset growth continues,AbbVie Inc. Sees Increased Institutional Support,Assetmark Inc. has...
Assetmark Inc. Increases Stake in CVS Health as Institutional Support Grows
November 10, 2024 07:40 AM PST| By Team Kalkine MediaHeadlines,Assetmark Inc. boosts its stake in CVS Health,Institutional investors continue to increase CVS Health holdings,CVS Health shows significant interest from large investors,Assetmark Inc. increased its position in CVS Health Co.,(NYSE:CVS),by...
Verdence Capital Advisors Increases Stake in Johnson & Johnson
November 10, 2024 03:21 AM PST| By Team Kalkine MediaHeadlines,Verdence Capital Advisors boosts its holdings in Johnson & Johnson, signaling continued interest in the healthcare leader.,Other institutional investors strengthen their positions in JNJ, highlighting broad support.,Johnson & Johnson mainta...
Positive Earnings Expected at Canopy Growth as Cost Savings Take Effect
November 08, 2024 09:47 AM PST| By Team Kalkine MediaHighlights:,Canopy Growth reports a positive outlook for adjusted EBITDA in upcoming quarters, driven by cost-saving initiatives.,The company’s Q2 fiscal 2025 results show a decline in revenue to C$63.0 million.,Cost-saving measures are expected to o...
Key Highlights from Iovance Biotherapeutics Inc. Q3 2024 Earnings Call Transcript
November 08, 2024 05:08 AM PST| By Team Kalkine MediaHighlights:,Iovance Biotherapeutics provides an update on its commercial launch of Amtagvi and its revenue guidance.,Key developments include progress on global regulatory submissions and pipeline updates.,Adoption and demand at authorized treatment...
Wall Street Analysts Express Positive Outlook on AbbVie Stock
November 07, 2024 03:17 AM PST| By Team Kalkine MediaHighlights,AbbVie Inc. has seen strong stock performance, outpacing both the broader market and sector indexes.,The company reported better-than-expected Q3 earnings, driven by strong sales of immunology drugs Rinvoq and Skyrizi.,AbbVie’s positive ea...
Baird Sees McKesson Stock Poised for Upside, Driven by US Pharma and Tech Solutions
November 07, 2024 02:53 AM PST| By Team Kalkine MediaHighlights:,Baird upgraded McKesson Corporation’s stock from Neutral to Outperform, raising its price target to $688 from $531.,McKesson's strong performance in the U.S. Pharmaceutical Distribution and Prescription Technology Solutions sectors drive...
Rhythm Pharmaceuticals Inc (RYTM) Discusses Revenue Growth and Global Expansion Strategy in Q3 2024 Earnings Call
November 07, 2024 02:40 AM PST| By Team Kalkine MediaHighlights:,Rhythm Pharmaceuticals reported strong revenue growth in Q3 2024, with total revenues of $33.3 million, marking a 14% quarter-over-quarter increase.,The company continues to make progress with its clinical programs, particularly for hypot...
Wedbush Begins Coverage of Rezolute (RZLT) with Outperform Rating
November 06, 2024 03:45 AM PST| By Team Kalkine MediaHighlights:,Wedbush Initiates Coverage:,Wedbush initiated coverage of Rezolute (NasdaqCM: RZLT) on November 5, 2024, with an,Outperform,rating.,Strong Price Upside Potential:,The average one-year price forecast for Rezolute suggests a potential upsid...
Revenue Rises to $30M in AnaptysBio Inc. (ANAB) Q3 2024, EPS of -$1.14 Exceeds Estimates
November 06, 2024 03:36 AM PST| By Team Kalkine MediaHighlights:,AnaptysBio's Q3 2024 revenue of $30.0 million significantly exceeded the analyst estimate of $6.87 million, driven by collaboration revenue and a commercial milestone.,The company reported a net loss of $32.9 million for Q3 2024, an impro...
Centene Sees Surge in Call Option Activity and Analyst Adjustments (NYSE)
November 06, 2024 03:34 AM PST| By Team Kalkine MediaHeadlines,Significant call option activity for Centene Corp.,Recent analysts adjust target price for Centene.,Large investors raise their positions in Centene stock.,Centene Sees Increased Call Option Activity (NYSE,),Centene Corporation,(NYSE:CNC),e...
CVS Health Co. (NYSE:CVS) Shares Sold by Janney Montgomery Scott LLC Firm
November 06, 2024 03:06 AM PST| By Team Kalkine MediaHighlights:,Janney Montgomery Scott LLC reduced its stake in CVS Health by 24.8% during Q3 2024.,CVS Health’s quarterly revenue increased by 2.6% year-over-year, with a return on equity of 12.72%.,The company announced a quarterly dividend with a yie...
Select Medical Holdings Announces Dividend with Strong Earnings Outlook
November 05, 2024 04:34 PM PST| By Team Kalkine MediaHeadlines,Select Medical Holdings Corporation announces a dividend of $0.125 per share.,Projected earnings suggest strong coverage for future distributions.,Dividend growth indicates a stable financial outlook for the company.,Select Medical Holdings...
Understanding Institutional Ownership in Johnson & Johnson
November 05, 2024 06:45 AM PST| By Team Kalkine MediaHeadlines,Strong institutional ownership influences Johnson & Johnson's stock dynamics,Institutional investors prioritize companies in major indices,The future outlook is critical for assessing investment potential,Johnson & Johnson,(NYSE:JNJ),showca...
